A new systematic review and network meta-analysis published in Wiley Online Library found that Tirzepatide-based drugs, including Mounjaro and Zepbound, may deliver greater weight loss than Semaglutide and Liraglutide. Researchers analysed data from over 14,000 adults with obesity, while experts stressed that medication choice should depend on individual health needs and medical advice.